Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).

Charles L Loprinzi; Rui Qin; Shaker R Dakhil; Louis Fehrenbacher; Kathleen A Flynn; Pamela Atherton; Drew Seisler; Rubina Qamar; Grant C Lewis; Axel Grothey

首页> 外文期刊>Journal of Clinical Oncology >Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).

【24h】

Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).

机译：静脉内钙和镁预防奥沙利铂诱导的感觉神经毒性（N08CB / Alliance）的III期随机，安慰剂对照，双盲研究。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

This study does not support using calcium/magnesium to protect against oxaliplatin-induced neurotoxicity.

机译：这项研究不支持使用钙/镁来预防奥沙利铂引起的神经毒性。

著录项

来源
《Journal of Clinical Oncology》 |2014年第10期|共9页
作者
Charles L Loprinzi; Rui Qin; Shaker R Dakhil; Louis Fehrenbacher; Kathleen A Flynn; Pamela Atherton; Drew Seisler; Rubina Qamar; Grant C Lewis; Axel Grothey;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献

1. Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). [J] . Charles L Loprinzi, Rui Qin, Shaker R Dakhil, Journal of Clinical Oncology . 2014,第10期

机译：静脉内钙和镁预防奥沙利铂诱导的感觉神经毒性（N08CB / Alliance）的III期随机，安慰剂对照，双盲研究。
2. Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). [J] . Charles L Loprinzi, Rui Qin, Shaker R Dakhil, Journal of Clinical Oncology . 2014,第10期

机译：静脉内钙和镁预防奥沙利铂诱导的感觉神经毒性（N08CB / Alliance）的III期随机，安慰剂对照，双盲研究。
3. Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). [J] . Charles L Loprinzi, Rui Qin, Shaker R Dakhil, Journal of Clinical Oncology . 2014,第10期

机译：III期随机，安慰剂控制，静脉钙和镁的双盲研究，以防止奥沙利铂诱导的感觉神经毒性（N08CB /联盟）。
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Phase III Randomized Placebo-Controlled Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance) [O] . Charles L. Loprinzi, Rui Qin, Shaker R. Dakhil, -1

机译：静脉钙和镁预防奥沙利铂引起的感觉神经毒性的III期随机安慰剂对照双盲研究（N08CB / Alliance）
7. Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy [O] . Toru Kono, Taishi Hata, Satoshi Morita, 2013

机译：Goshajinkigan奥沙利铂神经毒性评估（GONE）：goshajinkigan预防奥沙利铂引起的神经病的2期，多中心，随机，双盲，安慰剂对照试验

Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).

摘要

著录项

相似文献

相关主题

期刊订阅